Below are articles from various sources about members of MCB and their research.

October 20, 2017

Thanks to all faculty, staff, and researchers that attended our annual picnic this year!

October 10, 2017

What happens when academia and industry come together to share their passion for innovation and discovery? This synergy was sparked at the MCB Industrial Affiliates Program (IAP) inaugural symposium. 

Read more...

October 09, 2017

A group of UC researchers received funding to build the NexGen 7T functional MRI (fMRI) that will "provide the highest resolution images of the brain ever obtained, able to focus on a region the size of a poppy seed."

Read More...

October 06, 2017

MCB Professor David Bilder contributed this piece to the New York Times, expressing the beauty and importance of basic research -- and how critical it is to continue the government's support of it.

Read more...

October 05, 2017

Assistant Professor of Genetics, Genomics and Development Hernan Garcia and Assistant Adjunct Professor of Biochemistry, Biophysics and Structural Biology Jacob Corn received New Innovator Awards from the National Institutes of Health (NIH). The award supports highly creative, innovative research that could have implications for human health.

Read more... 

October 04, 2017

A study co-authored by MCB and Chemistry Professor, and HHMI Investigator, Jennifer Doudna details a safer and more effective method of delivering CRISPR-Cas9 gene-editing technology.

Read more...

October 04, 2017

We have just learned that MCB Emeritus Professor Satyabrata Nandi passed away on July 29th, 2017 in his home in Berkeley at the age of 86. He received his PhD from UC Berkeley in 1957, and ultimately joined us as a faculty member. His career in cancer research and teaching spanned over 40 years and he is still remembered fondly in the department.  

Read more...

September 28, 2017

The lab of MCB Associate Professor Michelle Chang has engineered E. coli to manufacture bioplastics from inorganic fluorides. The product is more durable than non-fluorinated commercial bioplastics, which could make bioplastic production more sustainable.

Read more...

September 20, 2017

A study co-authored by Associate Professor of MCB and Physics Ahmet Yildiz has revealed a critical region within the Cas9 protein that can be manipulated to improve its target specificity. This has the potential to greatly reduce the risk of inaccurate edits, a key consideration for the future of gene therapy in humans.

Read more...

September 19, 2017

4D Molecular Therapeutics, co-founded by MCB & BioEngineering Professor David Schaffer has received $3 million in funding from Cystic Fibrosis Foundation Therapeutics Inc.

4D Molecular Therapeutics is a developer and manufacturer of gene therapeutic products. The funding will help them begin clinical trials of a new gene therapy treatment, 4D-710, on cystic fibrosis patients.

Read more...